# A proposed workflow to robustly analyze bacterial transcripts in RNAseq data from extracellular vesicles

**Authors:** Alex M. Ascensión, Miriam Gorostidi-Aicua, Ane Otaegui-Chivite, Ainhoa Alberro, Rocio del Carmen Bravo-Miana, Tamara Castillo-Trivino, Laura Moles, David Otaegui

PMC · DOI: 10.3389/fmicb.2025.1486661 · Frontiers in Microbiology · 2025-03-20

## TL;DR

This paper introduces a new workflow to detect bacterial RNA in extracellular vesicles from blood samples, which could help understand how gut bacteria might influence diseases like multiple sclerosis.

## Contribution

A novel workflow for robust bacterial RNA detection in extracellular vesicles using RNA-seq data and taxonomic profiling tools.

## Key findings

- Bacterial RNA was successfully detected in EV RNA-seq data from blood samples.
- The workflow identified bacterial candidates differentially expressed between MS phases.
- The method includes biological and technical controls to ensure specificity and reduce false positives.

## Abstract

The microbiota has been unequivocally linked to various diseases, yet the mechanisms underlying these associations remain incompletely understood. One potential contributor to this relationship is the extracellular vesicles produced by bacteria (bEVs). However, the detection of these bEVs is challenging. Therefore, we propose a novel workflow to identify bacterial RNA present in circulating extracellular vesicles using Total EV RNA-seq data. As a proof of concept, we applied this workflow to a dataset from individuals with multiple sclerosis (MS).

We analyzed total EV RNA-seq data from blood samples of healthy controls and individuals with MS, encompassing both the Relapsing-Remitting (RR) and Secondary Progressive (SP) phases of the disease. Our workflow incorporates multiple reference mapping steps against the host genome, followed by a consensus selection of bacterial genera based on various taxonomic profiling tools. This consensus approach utilizes a flagging system to exclude genera with low abundance across profilers. Additionally, we included EVs derived from two cultured species that serve as biological controls, as well as artificially generated reads from 60 species as a technical control, to validate the specificity of this workflow.

Our findings demonstrate that bacterial RNA can indeed be detected in total EV RNA-seq from blood samples, suggesting that this workflow can be a powerful tool for reanalyzing RNA-seq data from EV studies. Additionally, we identified promising bacterial candidates with differential expression between the RR and SP phases of MS.

This approach provides valuable insights into the potential role of bEVs in the microbiota-host communication. Finally, this approach is translatable to other experiments using total RNA, where the lack of a robust pipeline can lead to an increased false positive detection of microbial genera. The workflow and instructions on how to use it are available at the following repository: https://github.com/NanoNeuro/EV_taxprofiling.

## Linked entities

- **Diseases:** multiple sclerosis (MONDO:0005301)

## Full-text entities

- **Diseases:** MS (MESH:D009103)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11981554/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11981554/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11981554/full.md

---
Source: https://tomesphere.com/paper/PMC11981554